Karl Groke

Title: The Innovative Contributions of Karl Groke

Introduction

Karl Groke is a notable inventor based in Eggersdorf, Austria. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work focuses on developing solutions that address critical health issues, particularly in cancer therapy.

Latest Patents

Among his latest patents is an "Intravenously Administrable Aqueous Solution." This invention involves a water-soluble, physiologically tolerable salt of sulfametrole and trimethoprim, enhanced with solubilizers such as malic acid, L-serine, and/or L-threonine. The solution is designed to maintain a pH of 6.5-7.0, making it suitable for intravenous administration. Another significant patent is the "Composition for Destroying Malignant Tumors." This agent contains alpha-ketoglutaric acid and 5-hydroxymethylfurfural as active substances, demonstrating a destructive effect on malignant tumors. It can be utilized in cancer therapy in various forms, including infusion solutions, oral or rectal administration, douches, or ointments.

Career Highlights

Karl Groke has worked with reputable companies such as Leopold & Co. Chem. Pharm. Fabrik Gesellschaft M.b.h. and Leopold & Co., Chem. Pharm. Fabrik Aktiengesellschaft. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Throughout his career, Groke has collaborated with notable individuals, including Erich Reichel and Heinz Schmidt-Kloiber. These partnerships have likely enriched his work and led to the development of impactful inventions.

Conclusion

Karl Groke's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to improving health outcomes. His work continues to influence cancer therapy and showcases the importance of research and development in medicine.